I thought when Mipomersen will be approved the stock would appreciate a lot. It went up only one dollar and change yesterday after the full extent of the data and the conference call info was revealed. I hardly find a dollar and change response very exiting. What am I missing here?
The approval was built in for the most part. I bought some $16 calls and $11 Puts as insurance in case ISIS managed to break the 52 week high. This is not a short term trade. If your looking for a quick buck this isn't the investment. As of late it has been unstable enough to be considered a slot machine more then an investment.
I think approval was mostly baked in. Crooke stated at the Jan. 9 JPM conference it was going to be approved. Pretty ballsy thing to say if he didn't already know (with a load of lawsuits already filed btw). Also at this conference he highlighted a number of catalysts for ISIS in the upcoming year. Look at the pps since the conference.
Most of the milestones look to be coming in the second half of 2013. Probably get an update on early catalysts at the Swann Healthcare conference on Feb. 14 & maybe some guidance on Kynamro sales.
JMHO - best to do your own dd